Plato Investment Management Ltd Acquires Shares of 39,281 Lam Research Corporation $LRCX

Key Points

• Plato Investment Management acquired 39,281 Lam Research shares worth approximately $16.9 million in the second quarter, making LRCX its 15th-largest holding. Institutional investors collectively own 84.61% of the company.
• Lam Research exceeded quarterly expectations, reporting $1.82 in EPS versus the $1.69 estimate and $6.72 billion in revenue, up 30% year over year. The company issued first-quarter 2027 EPS guidance of $2.00–$2.30.
• Analysts maintain a broadly positive view, with a consensus “Moderate Buy” rating and a $358.47 price target, although insiders sold 80,441 shares worth $27.6 million over the past 90 days.

Plato Investment Management Ltd bought a new stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 39,281 shares of the semiconductor company's stock, valued at approximately $16,922,000. Lam Research accounts for 1.0% of Plato Investment Management Ltd's holdings, making the stock its 15th largest position.

Several other institutional investors and hedge funds have also modified their holdings of the stock. World Equity Group Inc. boosted its position in Lam Research by 0.5% during the second quarter. World Equity Group Inc. now owns 5,576 shares of the semiconductor company's stock valued at $2,416,000 after purchasing an additional 29 shares during the last quarter. Tenzing Financial LLC raised its stake in shares of Lam Research by 3.5% during the 2nd quarter. Tenzing Financial LLC now owns 1,018 shares of the semiconductor company's stock worth $441,000 after purchasing an additional 34 shares in the last quarter. Gibraltar Capital Management Inc. lifted its holdings in shares of Lam Research by 3.6% during the 2nd quarter. Gibraltar Capital Management Inc. now owns 1,050 shares of the semiconductor company's stock valued at $455,000 after buying an additional 36 shares during the last quarter. Elevated Financial Group LLC lifted its holdings in shares of Lam Research by 3.0% during the 2nd quarter. Elevated Financial Group LLC now owns 1,223 shares of the semiconductor company's stock valued at $530,000 after buying an additional 36 shares during the last quarter. Finally, Yoder Wealth Management Inc. grew its stake in shares of Lam Research by 3.3% in the 2nd quarter. Yoder Wealth Management Inc. now owns 1,129 shares of the semiconductor company's stock valued at $489,000 after buying an additional 36 shares in the last quarter. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Stock Performance

Shares of LRCX opened at $310.17 on Tuesday. The company has a market capitalization of $388.12 billion, a PE ratio of 53.85, a price-to-earnings-growth ratio of 1.25 and a beta of 1.84. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. Lam Research Corporation has a one year low of $94.11 and a one year high of $438.50. The company's fifty day moving average price is $335.90 and its 200 day moving average price is $286.99.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same period last year, the business posted $1.33 earnings per share. The firm's revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, analysts expect that Lam Research Corporation will post 9.32 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently weighed in on LRCX. Wall Street Zen lowered shares of Lam Research from a "buy" rating to a "hold" rating in a research report on Sunday, May 10th. Citigroup restated a "buy" rating and set a $450.00 price target (up from $315.00) on shares of Lam Research in a research note on Wednesday, June 17th. Susquehanna restated a "positive" rating and set a $475.00 price target (up from $385.00) on shares of Lam Research in a report on Tuesday, June 30th. Raymond James Financial set a $425.00 price objective on shares of Lam Research in a report on Wednesday, June 10th. Finally, UBS Group reissued a "buy" rating and set a $375.00 target price (up from $310.00) on shares of Lam Research in a research report on Tuesday, June 9th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, Lam Research currently has a consensus rating of "Moderate Buy" and a consensus target price of $358.47.

Insider Buying and Selling at Lam Research

In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of Lam Research stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company's stock, valued at $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the company's stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the transaction, the director directly owned 199,205 shares of the company's stock, valued at approximately $69,881,114. This trade represents a 21.48% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 80,441 shares of company stock valued at $27,614,296 in the last ninety days. Company insiders own 0.31% of the company's stock.

About Lam Research

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source